Persistence of Genetic Mutations after Chemotherapy Linked to Poor Outcomes in Some Patients with AML



The persistence of genetic mutations in some patients with acute myeloid leukemia may allow physicians to better classify their risk of recurrence.



Source link

Comments are closed.